(0.14%) 5 334.75 points
(0.06%) 40 162 points
(0.21%) 18 674 points
(-0.70%) $79.50
(2.55%) $2.69
(0.19%) $2 421.90
(0.91%) $31.55
(-2.17%) $1 066.30
(0.13%) $0.921
(0.17%) $10.69
(0.05%) $0.787
(-0.40%) $90.60
Live Chart Being Loaded With Signals
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical...
Stats | |
---|---|
Today's Volume | 632 656 |
Average Volume | 524 391 |
Market Cap | 5.14B |
EPS | $0.240 ( 2024-05-01 ) |
Next earnings date | ( $0 ) 2024-07-31 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -15.26 |
ATR14 | $0.0160 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-24 | Stewart Andrew J. | Sell | 3 943 | Common Shares, No Par Value |
2024-04-24 | Bailey A Robert D | Sell | 9 838 | Common Shares, No Par Value |
2024-03-29 | Robertson Russel C | Buy | 1 481 | Common Shares, No Par Value |
2024-03-29 | Paulson John | Buy | 1 264 | Common Shares, No Par Value |
2024-03-29 | De Schutter Richard U | Buy | 1 553 | Common Shares, No Par Value |
INSIDER POWER |
---|
-5.60 |
Last 94 transactions |
Buy: 2 803 512 | Sell: 8 839 600 |
Volume Correlation
Bausch + Lomb Corporation Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Bausch + Lomb Corporation Correlation - Currency/Commodity
Bausch + Lomb Corporation Financials
Annual | 2023 |
Revenue: | $4.15B |
Gross Profit: | $2.50B (60.40 %) |
EPS: | $-0.740 |
FY | 2023 |
Revenue: | $4.15B |
Gross Profit: | $2.50B (60.40 %) |
EPS: | $-0.740 |
FY | 2022 |
Revenue: | $3.77B |
Gross Profit: | $2.25B (59.69 %) |
EPS: | $0.0429 |
FY | 2021 |
Revenue: | $3.77B |
Gross Profit: | $2.30B (61.04 %) |
EPS: | $0.520 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, and dry eye. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, ocular hypertension, and retinal diseases; and contact lenses for therapeutic use. The Surgical segment provides tools and technologies for the treatment of cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. The company was founded in 1853 and is headquartered in Vaughan, Canada.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators